StockVS

Garden Stage Limited (GSIW) Stock Analysis

Financial Services

Garden Stage Limited

$30.00

+$0.00 (+0.00%)

Last Updated: May 26, 2026

Price History

Analysis

Company Overview

Garden Stage Limited operates within the Financial Services sector, specifically focusing on the Capital Markets industry, where it delivers a comprehensive suite of financial solutions to clients in Hong Kong. The company's core operations encompass securities dealing and brokerage services, alongside underwriting and placing services, investment advisory, due diligence, referral, and asset management. With a market capitalization of $23.16M and annual revenue of $8.09M, Garden Stage Limited represents a small-cap entity with limited disclosed employee data. These valuation and revenue figures indicate that the company is a micro-cap player with a relatively modest operational footprint compared to major regional competitors. The significant disparity between its revenue and market cap suggests a pricing dynamic heavily influenced by market sentiment rather than current earnings power, characteristic of early-stage or turnaround financial service firms.

Financial Health

The company reported a revenue of $8.09M for the trailing twelve months, yet it recorded a net income of $-7,537,693, while EBITDA data is not available for this reporting period. The substantial gap between the positive revenue of $8.09M and the severe negative net income reveals a highly fragile cost structure where operating expenses far exceed gross profits, resulting in a loss of more than seven million dollars. Free cash flow is not reported for Garden Stage Limited, which implies that the firm lacks the immediate cash generation required to fund operations without relying on external capital or asset liquidation. Gross margin stands at 5.3%, indicating that the company retains only a small fraction of sales revenue after direct costs, a typical but precarious position for brokerage and dealing firms. Operating margin is reported at -192.2%, and profit margin is -93.2%, both figures signaling that for every dollar of revenue, the company loses money on a significant scale before and after interest and taxes. In terms of leverage, the company holds $10.30M in cash against $140,745 in debt, supported by a debt-to-equity ratio of 0.71. This liquidity profile suggests a conservative balance sheet regarding solvency, as the cash reserves vastly outweigh the outstanding debt obligations. The current ratio of 2.51 further indicates strong short-term liquidity, meaning the company possesses $2.51 in current assets for every dollar of current liabilities. However, the return on equity is -56.3% and the return on assets is -31.4%, metrics that reveal management has been ineffective at generating returns on the capital deployed by shareholders and creditors.

Valuation Assessment

Trailing P/E and forward P/E ratios are not available due to the company's negative earnings, preventing a direct comparison of expected earnings trajectories via traditional multiple analysis. The price-to-book ratio is 0.90, which indicates that the market is valuing the company at slightly less than its book value, suggesting no significant market premium over the net asset value recorded on the balance sheet. The price-to-sales ratio stands at 2.86, while EV/EBITDA is not available, suggesting that valuation is being driven primarily by sales multiples rather than earnings or enterprise value multiples. The stock has traded between a 52-week low of $8.00 and a 52-week high of $358.00, exhibiting extreme volatility. Without a specific current share price provided in the available facts, the exact percentage distance from the high or low cannot be calculated, but the range itself demonstrates a massive swing of over 340% during the last year. The beta value is 2.30, which signifies that the stock is expected to be roughly 2.3 times more volatile than the broader market, amplifying both gains and losses during market movements. This high beta reflects the speculative nature of small-cap financial stocks that lack consistent earnings to anchor their price stability.

Growth & Income

Revenue growth year-over-year is reported at 414.6%, whereas earnings growth is not available, implying that top-line expansion has not yet translated into profitability or that losses are widening despite increased sales. Since the company does not pay dividends, the dividend yield and payout ratio are not applicable, meaning the firm retains all of its earnings—or in this case, its losses—to fund operations or strategic initiatives rather than returning capital to shareholders. The absence of a dividend payout ratio confirms that the company is not currently in a position to distribute income, likely due to the persistent net losses and the need to preserve the $10.30M cash balance. The overall growth and income profile is characterized by explosive top-line expansion coupled with significant operating losses and a complete absence of income distribution to investors.

Peer Comparison

Garden Stage Limited (GSIW) operates in the Capital Markets industry. Here is how it compares to its closest peers by market capitalization:

Company Ticker Market Cap P/E Ratio
Garden Stage Limited GSIW $42.37M N/A
Morgan Stanley MS $317.08B 18.2
The Goldman Sachs Group, Inc. GS $293.39B 18.1
The Charles Schwab Corporation SCHW $155.48B 17.8

The Capital Markets industry average P/E ratio is 20.3x. Garden Stage Limited trades at a P/E of N/A.

This analysis is AI-generated for informational purposes only and should not be considered financial advice. Data may be delayed or inaccurate. Always do your own research and consult a qualified financial advisor before making investment decisions.

About Garden Stage Limited

Garden Stage Limited, through its subsidiaries, provides financial services in Hong Kong. It offers securities dealing and brokerage services; underwriting and placing services; investment advisory services; due diligence services; introduction and referral services; and asset management services, such as account and fund management services. The company was incorporated in 2022 and is headquartered in Central, Hong Kong. Garden Stage Limited is a subsidiary of Oriental Moon Tree Limited.

Visit website →

Key Statistics

Market Cap
$42.37M
P/E Ratio
N/A
52-Week High
$358.00
52-Week Low
$8.00
Avg Volume
53.09K
Beta
4.25

Data provided by Yahoo Finance via yfinance. Updated daily.

Company Info

Exchange
NASDAQ
Country
Hong Kong